Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes

Citation
S. Dokka et al., Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes, PHARM RES, 17(5), 2000, pp. 521-525
Citations number
15
Language
INGLESE
art.tipo
Article
Categorie Soggetti
Pharmacology & Toxicology
Journal title
PHARMACEUTICAL RESEARCH
ISSN journal
0724-8741 → ACNP
Volume
17
Issue
5
Year of publication
2000
Pages
521 - 525
Database
ISI
SICI code
0724-8741(200005)17:5<521:ORPTIB>2.0.ZU;2-7
Abstract
Purpose, The objectives of this study are to investigate the toxicity assoc iated with polycationic liposomes and to elucidate the underlying mechanism . We tested the hypothesis that the positive charge of liposomes is a key d eterminant of toxicity by testing differently charged liposomes in mice. Methods. Differently charged liposomal systems including cationic liposomes , LipofectAMINE acid DOTAP, and neutral and negative liposomes were evaluat ed for their toxicity after pulmonary administration in mice. LDH assay and differential cell counts were performed to measure toxicity and pulmonary inflammation, respectively. Reactive oxygen intermediates (ROI) were assess ed by chemiluminescence. Results. Instillation of cationic liposomes elicited dose-dependent toxicit y and pulmonary inflammation. This effect was more pronounced with the mult ivalent cationic liposome LipofectAMINE as compared to the monovalent catio nic DOTAP. Neutral and negative liposomes did not exhibit lung toxicity. To xicity associated with cationic liposomes correlated with the oxidative bur st induced by the liposomes. LipofectAMINE induced a dose-dependent increas e in ROI generation. This effect was less pronounced with DOTAP and absent with neutral and negative liposomes. Conclusions. ROI play a key role in cationic lipid-mediated toxicity. Polyv alent cationic liposomes cause a release of ROI which are responsible for t he pulmonary toxicity.